Genetic Fate Mapping Reveals Endothelial Cells During Venous Thrombus Resolution – RPTH Journal
RPTH Journal shared a post on LinkedIn about a recent article by Magdalena L. Bochenek et al, adding:
“New RPTH research used a genetic fate mapping approach to visualize tamoxifen–inducible endothelial receptor tyrosine kinase (TIE2) reporter ECs during venous thrombus resolution and human pulmonary thrombi of different organizational stages to validate findings.
This time course analysis may aid the refinement of revascularization strategies in humans.
Tune in as co-authors Katrin Schäfer and Magdalena Bochenek discusses this new research with RPTH social media associate editor Nicolas Gendron.”
Title: Visualization of new vessel formation during venous thrombus organization using genetic fate mapping
Authors: Magdalena L. Bochenek, Julie D. Noorali, Aden Aderajew, Kateryna Moiko, Stefanie Zimmer, Konstantinos Zifkos, Mathias Wagner, Philipp Lurz, Lukas Hobohm, Katrin Schäfer
More posts featuring RPTH Journal on Hemostasis Today.
-
Sep 19, 2026, 03:15Paulus Kirchhof: Europe’s Safe Hearts Plan to Reduce Cardiovascular Mortality
-
Sep 19, 2026, 03:10James Smith: Brain Training and Exercise for Cognitive Recovery After Stroke
-
Sep 19, 2026, 03:03Lesley Van Wyk: ASH Releases New Iron Deficiency Diagnosis Guidelines
-
Sep 19, 2026, 02:53Francisco Chacón-Lozsán: Acute Ischemic Stroke in 2026 – Expanding the Treatment Window
-
Sep 19, 2026, 01:53Thomas Dayspring: Understanding Genome and Lipid Interactions in Lipidology
-
Sep 19, 2026, 01:47Abdurrahman Tufan: Combination Targeted Therapy in Refractory Systemic Autoinflammatory Diseases
-
Sep 19, 2026, 01:44Patrick James Lynch: Mother of a Thousand Sons Premieres at BDC 2026
-
Sep 19, 2026, 01:39Mostafa Hammam: Three Different Platelet Defects – One Common Symptom
-
Sep 19, 2026, 01:38Jeff Sternlicht: A Heart Attack Should Not Be the Starting Line